CircInterventions

In patients with renal dysfunction oral nicorandil can enhance renoprotection beyond periprocedural hydration. Nicorandil to Prevent Contrast-Associated Kidney Injury in High-Risk PCI ahajrnls.org/4oN5UEB

Can Aortic Root Rupture be averted in bicuspid valve anatomy? ABC Sizing Algorithm for Bicuspid Valves Treated with SAPIEN 3. Presented at @TCTConference #NYValves2026 and published simultaneously @docsuleman ahajrnls.org/4xQx29R

High procedural success, RV reverse remodeling and excellent durability. Prospective Midterm Outcomes of the PULSTA Self-expandable Transcatheter Pulmonary Valve: The PULSTA CE approval study @profahmetcelebi ahajrnls.org/4eATuek

Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights from SYMPHONY-PE. No difference in safety event rates with early thrombectomy despite larger reduction in RV/LV and mean PAP @AqamarMD @samsayfo @hgl @SripalBangalore ahajrnls.org/4xEqMlo

Technical success of fetal aortic valvuloplasty. A report from the International Fetal Cardiac Intervention Registry. Fetal gestational age and number of cardiac punctions predicts outcome and not volume @jmsimpsonmd @ShaineMorris1 @cruzlemini ahajrnls.org/49TmGvQ

Impact of revascularization completeness on cardiovascular outcomes in STEMI with multivessel disease. Complete revascularization strategy may be related to the extent of anatomical completeness of revascularization @PHRIresearch @BaineyKevin @drnataliap ahajrnls.org/3PNStaF

Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis from the EARLY TAVR trial. Early TAVR versus clinical survelliance consistent among all age groups above 65 years @kashishgoelmd @PhilGenereuxMD ahajrnls.org/3PZmWmc

Comparison of Drug-Coated versus Conventional Balloons for side branches in bifurcation lesions: OCVC-BIF Study Reduced side branch restenosis with DCB at 9 months ahajrnls.org/3RPKpXC

Presenting at @escardio #ESCCongress 2026? Submit your work by June 22 for expedited consideration for simultaneous publication in Circ Interventions & maximize the visibility and impact of your research. ahajournals.org/esc #cardiotwitter #ESCCongress2026 #ESC2026

In patients undergoing TAVI the extent of myocardium at risk predicts outcomes. Clinical impact of jeopardized myocardium extent in TAVI @espogiov @azeemlatib @GGStefanini @BiascoDr @MattiAdam_MD @fortuiaco @MarkusMach @kargoli @DaijiroTomii @MDMainardi ahajrnls.org/43vsDv0

Does the clinical benefit of intravascular imaging-guided PCI differ between focal & diffuse CAD? A LBCT presented at #EuroPCR & published simultaneously @ColinBerryMD @wfearonmd @divaka_perera @fer_iver @juliendjdj @SimoneBiscaglia @DrAllenJ @DMunhoz ahajrnls.org/3Ps2jPh

Reduced device-related thrombosis with direct oral anticoagulant vs. dual antiplatelet therapy after left atrial appendage closure. Presented at #EuroPCR and published simultaneously @NicolaAmmir ahajrnls.org/4dSXKqm

Angiography-derived FFR versus IVUS to guide PCI according to angiographic lesion characteristics. Presented at #EuroPCR and published simultaneously @wfearonmd ahajrnls.org/4nDM9Pd

How do you use paclitaxel-coated balloons? Real-world use of AGENT DCB in the U.S. after FDA approval. 1/5 patients treated with DCB for ISR @matthewjpricemd @ajaykirtane @KateKearney4 @ziadalinyc @EricSecemskyMD @ChristinaLalani @RafaelCav_MD @rwyeh ahajrnls.org/4nEILnl

Measured vs. Predicted Prosthesis-Patient Mismatch after TAVR for Bicuspid Aortic Valve. Outcomes from the AD-HOC Registry @G_Tarantini01 @tommaso_fabris @AndreaScotti21 @dr_ofir @LandesUri @azeemlatib ahajrnls.org/3PiLKVU

2/ Clinical efficacy to be assessed in the FRACTURE trial @RafaelCav_MD ahajournals.org/doi/10.1161/CI…

1/ Could Laser-and Optics-Based Intravascular Lithotripsy be as effective as the present electrical copper-wire based discharge system for the treatment of calcified coronary stenoses: the RESTORE First-In-Human Study ...

1-year Outcomes after Transcatheter Tricuspid Valve Repair. TTVr patients with improved survival when TR reduced to moderate or less compared to screen failures. Insights from the TriSelect Study @JamesDThomasMD1 @ChrisMalaisrie @MGercek40 @AkhilNarangMD ahajrnls.org/4fawNQ4

A novel low-profile (10F) percutaneous LV support device with up to 5.5 L/min demonstrates favorable performance and device-related safety in an early high-risk PCI feasibility study. The SUPPORT I Study. @azeemlatib @Kandzari ahajrnls.org/3QVIyzX

Contrast-derived index of microvascular resistance (cIMR): a novel index for measuring coronary microvascular resistance. @RoccoMontone @enromagnoli @KayserSoze84 @domdoct ahajrnls.org/48RbT4K